Atlanta Braves Holdings EVP sells 186,588 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Atlanta Braves Holdings, Inc. reported that EVP, Development Michael P. Plant exercised options for and sold Series C Common Stock from November 9 through November 11, 2026. He exercised options for 57,395 shares on November 9 and 57,000 shares on each of November 10 and 11 at $27.18 per share, then sold the corresponding directly held shares at weighted-average prices of $51.28 (range $50.43–$52.04), $52.21 (range $51.57–$52.62), and $51.79 (range $51.36–$52.13), respectively. The three direct sales were effected pursuant to a Rule 10b5-1 sales plan adopted August 7, 2026. A separate sale covered 15,193 shares held indirectly through a Grantor Retained Annuity Trust, at $52 per share. Total reported sales were 186,588 shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock option (Right to Buy) - BATRK F2 | 57,000 | $0.00 | $0.00 |
| Exercise | Series C Common Stock | 57,000 | $27.18 | $1.55M |
| Sale | Series C Common Stock F2, F5 | 57,000 | $51.79 | $2.95M |
| Sale | Series C Common Stock F1 | 15,193 | $52.00 | $790K |
| Exercise | Stock option (Right to Buy) - BATRK F2 | 57,000 | $0.00 | $0.00 |
| Exercise | Series C Common Stock | 57,000 | $27.18 | $1.55M |
| Sale | Series C Common Stock F2, F4, F1 | 57,000 | $52.21 | $2.98M |
| Exercise | Stock option (Right to Buy) - BATRK F2 | 57,395 | $0.00 | $0.00 |
| Exercise | Series C Common Stock F1 | 57,395 | $27.18 | $1.56M |
| Sale | Series C Common Stock F2, F3 | 57,395 | $51.28 | $2.94M |
Footnotes (5)
- F1. Includes (i) 23,925 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to him in satisfaction of the GRAT's annuity obligation on December 7, 2023, that were inadvertently not reflected in the reporting person's previously reported holdings, and (ii) 16,385 shares of Series C Common Stock previously held indirectly by the reporting person through his GRAT and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation on November 10, 2026.
- F2. The sales reported in this Form 4 and identified by this footnote were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 7, 2026.
- F3. Reflects the weighted average sale price. The range of prices for such transaction is $50.43 to $52.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- F4. Reflects the weighted average sale price. The range of prices for such transaction is $51.57 to $52.62. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- F5. Reflects the weighted average sale price. The range of prices for such transaction is $51.36 to $52.13. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Key Figures
Key Terms
Rule 10b5-1 sales plan financial
Grantor Retained Annuity Trust financial
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.